What is ACRS stock price today?

Visit our real-time dashboard for the current ACRS stock price and live market data.

Is ACRS stock going up or down today?

ACRS stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ACRS stock now?

The decision to buy ACRS depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ACRS a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ACRS based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ACRS stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ACRS is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ACRS's P/E ratio?

P/E ratio data for ACRS will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ACRS's market cap?

ACRS (Aclaris Therapeutics Inc) has a market capitalization of $0.62 billion, making it a small-cap stock.

What is ACRS's price to book ratio?

ACRS trades at a price-to-book (P/B) ratio of 4.29, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ACRS pay dividends?

ACRS does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ACRS's dividend yield?

ACRS does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ACRS stock a good long-term investment?

ACRS's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ACRS's revenue growth rate?

Revenue growth data for ACRS is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ACRS are available on our dashboard with complete income statement analysis.

What are the risks of investing in ACRS?

Key risks for ACRS include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ACRS compare to its competitors?

Compare ACRS to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ACRS's performance and positioning.

What is ACRS's stock price target for 2026?

Visit our prediction page for AI-powered price targets for ACRS with bull, base, and bear case scenarios.

What do analysts say about ACRS?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ACRS. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ACRS's next earnings report?

ACRS reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ACRS - Aclaris Therapeutics Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Aclaris Therapeutics Inc

Aclaris Therapeutics Inc (ACRS) common stock

Price Chart

Loading chart...

ACRS Key Statistics

Market Cap

$615.92M

P/B Ratio

4.29

How ACRS Compares to Peers

ACRS is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ACRS(This stock)	$615.92M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 20, 2026 at 4:19 PM EDT

Ready to invest in ACRS?

Commission-free trading available. Affiliate links.

ACRS Lician Score

10% confidence

6.0/10

Good

ACRS has a Lician Score of 6/10 (Good). Strengths: Growth.

value

5.0

growth

8.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ACRSacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ACRS Financial Snowflake

5-axis analysis across key investment dimensions

5.6/10

Neutral

5.0

Value

Valuation vs. sector peers

8.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for ACRS

Dashboard

Enter a ticker to analyze